Physician

Charles E Woodall, MD

According to 2025 Medicare claims, Charles Woodall, MD (NPI: 1730279506) practices surgical oncology in the Springfield, MO market, with the plurality of this provider's patient population coming from Greene, MO. This provider's primary affiliated billing organization is LESTER E COX MEDICAL CENTERS (NPI: 1760405864; TIN: 542183221) and primary practice location at 65807-9998.

Woodall's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 375 traditional Medicare patients, billed 1,656 HCPCS/CPT codes, and received $198,415 in Medicare payments. The top billing code was 43274 (Insertion of stent into pancreatic or bile duct using a flexible endoscope). Part D data shows 401 prescription claims across 269 beneficiaries totaling $48,743 in drug costs, led by Creon (Lipase/Protease/Amylase). 2023 DME data shows 50 claims. Open Payments data shows 2 records totaling $47. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $62,437 to $48,743. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $954 to $1,957.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	554	2,464	$259,793
2016	593	2,396	$255,401
2017	635	2,597	$262,276
2018	673	2,563	$291,068
2019	535	2,008	$241,898
2020	411	1,557	$196,525
2021	417	1,805	$239,727
2022	428	1,579	$197,390
2023	387	1,507	$203,833
2024	375	1,656	$198,415

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	269	1,278	$62,437
2016	272	988	$86,918
2017	229	801	$80,102
2018	262	837	$67,198
2019	250	662	$49,804
2020	221	396	$37,486
2021	217	390	$56,465
2022	214	334	$28,781
2023	265	393	$37,237
2024	269	401	$48,743

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$180
2016	N/R	96	$31,698
2017	N/R	11	$43
2018	N/R	158	$99,227
2019	N/R	222	$108,155
2020	N/R	114	$40,259
2021	N/R	68	$6,425
2022	N/R	N/R	N/R
2023	N/R	50	$4,194
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
43274	Insertion of stent into pancreatic or bile duct using a flexible endoscope	59	67	$299
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	59	59	$107
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	64	70	$95
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	101	371	$36
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	102	130	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Creon	Lipase/Protease/Amylase	14	439	$39,439
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	165	831	$1,027
Sucralfate	Sucralfate	31	900	$977
Oxycodone Hcl	Oxycodone Hcl	49	305	$866
Omeprazole	Omeprazole	33	1,020	$273

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$47	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles E. Woodall, MD?

Tedicare shows public-source Medicare data for Charles E. Woodall, MD (NPI 1730279506), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles E. Woodall, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles E. Woodall, MD?

Charles E. Woodall, MD is linked to LESTER E COX MEDICAL CENTERS (billing NPI 1760405864) in the available physician profile data.

Does Charles E. Woodall, MD have Open Payments data?

Charles E. Woodall, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.